MOSAIC is a seven-year global project to accelerate introduction and scale-up of new biomedical prevention products and expedite their availability, acceptance, uptake, and impact in PEPFAR programs to help individuals, especially women, prevent HIV and other infectious diseases.
In July, MOSAIC staff traveled to Munich, Germany, for AIDS 2024. The five of us were fortunate to be among our MOSAIC colleagues in attendance. In this post, we share some of our conference reflections, highlighting three key themes that emerged across our session attendance and participation.
Continue Reading
It’s an exciting time for HIV prevention. New products including PrEP ring and CAB PrEP are making their way into the market, and AGYW are poised to have a choice of method for the very first time. Just as the PrEP landscape is rapidly evolving, so too is the world in which young women are coming of age—and our marketing efforts must keep up if we want to remain relevant to our audience.
Continue Reading
MOSAIC is heading to Munich, Germany, for the International AIDS Conference (AIDS 2024). We invite conference attendees to join us for the following sessions.
Continue Reading
As the HIV prevention field continues to grow and introduce new HIV prevention methods such as the PrEP ring and CAB PrEP, individuals have more options to choose from. But having options alone does not equal having choice. To benefit from the availability of multiple PrEP options, PrEP users need to be able to make an informed choice.
Continue Reading
In this webinar, Ministry of Health leaders and partners from Zambia and Zimbabwe reflect on their early implementation experience and share critical learnings for other countries poised to introduce CAB PrEP this year.
Continue Reading
Gender-diverse adolescents and young people face barriers to accessing and taking HIV preventive medication. MOSAIC has adapted the original, family planning-focused Breakthrough ACTION Empathways card deck to help build provider empathy for LGBTQIA+ and sexual and gender minority PrEP clients of all ages.
Continue Reading
Last week, MOSAIC staff from Nigeria traveled to Cotonou, Benin, for the International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST). They participated in the conference in person and, in this post, share their reflections.
Continue Reading
MOSAIC is heading to Cotonou, Benin, for the International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST). We invite conference attendees to join us for the following sessions.
Continue Reading
For the first time, with the PrEP ring and CAB PrEP entering markets alongside oral PrEP, women have multiple HIV prevention methods to choose from. Now prevention programs face another first: how to deliver those options in ways that ensure informed choice and foster effective use. To help answer that question, MOSAIC embedded a quality improvement collaborative into its flagship CATALYST study.
Continue Reading
Zambia stands at the forefront of a groundbreaking journey in HIV prevention. With its recent accomplishment of being the first country outside the U.S. to administer CAB PrEP, Zambia reaffirms its commitment to advancing access to HIV prevention technologies. However, the successful rollout of such innovations goes beyond product availability.
Continue Reading